Overview

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Status:
Not yet recruiting

Trial end date:
2025-05-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare induction chemotherapy (TPF or GP) plus radiotherapy alone with induction chemotherapy plus concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC).

Phase:

Phase 3

Details

Lead Sponsor:

West China Hospital

Treatments:

Cisplatin
Docetaxel
Fluorouracil
Gemcitabine